Who is sponsoring NCT06839924?

NCT06839924 is sponsored by Cairo University.

What drugs are being tested in NCT06839924?

Interventions in NCT06839924: Cognitive Motor Interference, traditional physical therapy.

What condition does NCT06839924 study?

NCT06839924 studies Multiple Sclerosis, MS.

Is NCT06839924 still recruiting?

NCT06839924 is currently active, enrolled. Last updated 21 February 2025.

Last reviewed 2025-02-21 · How we verify

NCT06839924

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Motor Cognitive Interference on Cognition and Quality of Life on Patients with Multiple Sclerosis

Active, enrolled NA Last updated 21 February 2025

What this trial tests

NA trial testing Cognitive Motor Interference in Multiple Sclerosis, MS in 44 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

10 December 2024

Primary endpoint
12 June 2025

1 August 2025

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	44
Start date	10 December 2024
Primary completion	12 June 2025
Estimated completion	1 August 2025
Sites	1 location across Egypt

Drugs / interventions tested

Cognitive Motor Interference
traditional physical therapy

Conditions studied

Multiple Sclerosis, MS — all drugs for Multiple Sclerosis, MS →

Sponsor

Cairo University

Who can join

Adults 25 to 45, any sex, with Multiple Sclerosis, MS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Is there an effect of Cognitive Motor Interference on Cognition and quality of life on Multiple Sclerosis patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis, MS

Currently open trials in the same condition.

NCT06800144 — Effect of Music Therapy on Pain in People With Multiple Sclerosis · NA · recruiting
NCT06957145 — Vista Protein Expression of Monocyte and T Cell Subsets in Multiple Sclerosis and Its Clinical Correlation · recruiting
NCT06860932 — A Palliative Care Model Impact on Knowledge and Attitudes · NA · recruiting
NCT06541626 — Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06839924 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 21 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06839924.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing